| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c5d71634686a37933c2be65413ac95d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b0ddaf7ea825f3743ce5100d3576df2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38103a00afd8f8e504ca1df1d2db4211 |
| publicationDate |
2021-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210146108-A |
| titleOfInvention |
Pharmaceutical composition for preventing and treating cancer |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating cancer, and more particularly, to a pharmaceutical composition comprising a histone deacetylation inhibitor (HDAC inhibitor) and cisplatin as active ingredients. . The pharmaceutical composition according to the present invention can effectively inhibit the proliferation of cancer cells or cancer stem cells by using a histone deacetylation inhibitor and cisplatin together, thereby preventing or treating cancer, as well as resistance to anticancer agents, or cancer Metastasis or recurrence can also be prevented. |
| priorityDate |
2020-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |